Johns Hopkins Medicine has been awarded more than $18 million from the Defense Advanced Research Projects Agency (DARPA) to lead a multi-institutional effort to develop a novel extracorporeal membrane oxygenation (ECMO) and advanced life-support system device. ECMO devices assist patients by enabling heart and lung function when their organs are too damaged or weak to function normally.
